5376 related articles for article (PubMed ID: 17008531)
1. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
Galon J; Costes A; Sanchez-Cabo F; Kirilovsky A; Mlecnik B; Lagorce-Pagès C; Tosolini M; Camus M; Berger A; Wind P; Zinzindohoué F; Bruneval P; Cugnenc PH; Trajanoski Z; Fridman WH; Pagès F
Science; 2006 Sep; 313(5795):1960-4. PubMed ID: 17008531
[TBL] [Abstract][Full Text] [Related]
2. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.
Pagès F; Kirilovsky A; Mlecnik B; Asslaber M; Tosolini M; Bindea G; Lagorce C; Wind P; Marliot F; Bruneval P; Zatloukal K; Trajanoski Z; Berger A; Fridman WH; Galon J
J Clin Oncol; 2009 Dec; 27(35):5944-51. PubMed ID: 19858404
[TBL] [Abstract][Full Text] [Related]
3. The essential role of the in situ immune reaction in human colorectal cancer.
Pagès F; Galon J; Fridman WH
J Leukoc Biol; 2008 Oct; 84(4):981-7. PubMed ID: 18559950
[TBL] [Abstract][Full Text] [Related]
4. Coordination of intratumoral immune reaction and human colorectal cancer recurrence.
Camus M; Tosolini M; Mlecnik B; Pagès F; Kirilovsky A; Berger A; Costes A; Bindea G; Charoentong P; Bruneval P; Trajanoski Z; Fridman WH; Galon J
Cancer Res; 2009 Mar; 69(6):2685-93. PubMed ID: 19258510
[TBL] [Abstract][Full Text] [Related]
5. The clinical utility of the local inflammatory response in colorectal cancer.
Richards CH; Roxburgh CS; Powell AG; Foulis AK; Horgan PG; McMillan DC
Eur J Cancer; 2014 Jan; 50(2):309-19. PubMed ID: 24103145
[TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
[TBL] [Abstract][Full Text] [Related]
7. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
[TBL] [Abstract][Full Text] [Related]
9. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.
Lin YH; Friederichs J; Black MA; Mages J; Rosenberg R; Guilford PJ; Phillips V; Thompson-Fawcett M; Kasabov N; Toro T; Merrie AE; van Rij A; Yoon HS; McCall JL; Siewert JR; Holzmann B; Reeve AE
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):498-507. PubMed ID: 17255271
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.
Tosolini M; Kirilovsky A; Mlecnik B; Fredriksen T; Mauger S; Bindea G; Berger A; Bruneval P; Fridman WH; Pagès F; Galon J
Cancer Res; 2011 Feb; 71(4):1263-71. PubMed ID: 21303976
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.
Mlecnik B; Tosolini M; Kirilovsky A; Berger A; Bindea G; Meatchi T; Bruneval P; Trajanoski Z; Fridman WH; Pagès F; Galon J
J Clin Oncol; 2011 Feb; 29(6):610-8. PubMed ID: 21245428
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated antigen recognized by the 22-1-1 monoclonal antibody encourages colorectal cancer progression under the scanty CD8+ T cells.
Oshikiri T; Miyamoto M; Morita T; Fujita M; Miyasaka Y; Senmaru N; Yamada H; Takahashi T; Horita S; Kondo S
Clin Cancer Res; 2006 Jan; 12(2):411-6. PubMed ID: 16428480
[TBL] [Abstract][Full Text] [Related]
13. The adaptive immune response to colorectal cancer: from the laboratory to clinical practice.
Curtis NJ; Primrose JN; Thomas GJ; Mirnezami AH; Ottensmeier CH
Eur J Surg Oncol; 2012 Oct; 38(10):889-96. PubMed ID: 22721580
[TBL] [Abstract][Full Text] [Related]
14. Infiltration of Lynch colorectal cancers by activated immune cells associates with early staging of the primary tumor and absence of lymph node metastases.
de Miranda NF; Goudkade D; Jordanova ES; Tops CM; Hes FJ; Vasen HF; van Wezel T; Morreau H
Clin Cancer Res; 2012 Mar; 18(5):1237-45. PubMed ID: 22261803
[TBL] [Abstract][Full Text] [Related]
15. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer.
Roxburgh CS; McMillan DC
Cancer Treat Rev; 2012 Aug; 38(5):451-66. PubMed ID: 21945823
[TBL] [Abstract][Full Text] [Related]
16. TNM staging in colorectal cancer: T is for T cell and M is for memory.
Broussard EK; Disis ML
J Clin Oncol; 2011 Feb; 29(6):601-3. PubMed ID: 21245434
[No Abstract] [Full Text] [Related]
17. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.
de Jong RA; Leffers N; Boezen HM; ten Hoor KA; van der Zee AG; Hollema H; Nijman HW
Gynecol Oncol; 2009 Jul; 114(1):105-10. PubMed ID: 19411095
[TBL] [Abstract][Full Text] [Related]
18. T-cell response to p53 tumor-associated antigen in patients with colorectal carcinoma.
Bueter M; Gasser M; Schramm N; Lebedeva T; Tocco G; Gerstlauer C; Grimm M; Nichiporuk E; Thalheimer A; Thiede A; Meyer D; Benichou G; Waaga-Gasser AM
Int J Oncol; 2006 Feb; 28(2):431-8. PubMed ID: 16391798
[TBL] [Abstract][Full Text] [Related]
19. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
20. A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells).
Yoshida N; Kinugasa T; Miyoshi H; Sato K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y; Ohshima K
Ann Surg Oncol; 2016 Mar; 23(3):919-27. PubMed ID: 26564244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
